BRIM Biotechnology, Inc. (TPE:6885)

BRIM Biotechnology Revenue

BRIM Biotechnology had revenue of 2.82M TWD in the quarter ending March 31, 2026, with 2,723.00% growth. This brings the company's revenue in the last twelve months to 8.21M, up 1,796.77% year-over-year. In the year 2025, BRIM Biotechnology had annual revenue of 5.49M with 1,548.65% growth.

• Revenue (ttm): 8.21M
• Revenue Growth: +1,796.77%
• P/S Ratio: 335.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.49M	5.16M	1,548.65%
Dec 31, 2024	333.00K	243.00K	270.00%
Dec 31, 2023	90.00K	-436.00K	-82.89%
Dec 31, 2022	526.00K	166.00K	46.11%
Dec 31, 2021	360.00K	-90.41M	-99.60%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error